Fernández-Parra Rocio, Pey Pascaline, Reinero Carol, Malvè Mauro
Department of Small Animal Medicine and Surgery, Faculty of Veterinary Medicine, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain.
Antech Imaging Services, Irvine, CA, United States.
Front Vet Sci. 2023 Jul 18;10:1176757. doi: 10.3389/fvets.2023.1176757. eCollection 2023.
Salbutamol is a bronchodilatator commonly used for the treatment of feline inflammatory lower airway disease, including asthma or acute bronchospasm. As in humans, a pressurized metered dose inhaler (pMDI) is used in conjunction with a spacer and a spherical mask to facilitate salbutamol administration. However, efficacy of inhalation therapy is influenced by different factors including the non-cooperative character of cats. In this study, the goal was to use computational fluid dynamics (CFD) to analyze the impact of breathing patterns and salbutamol particle size on overall drug transport and deposition using a specific spherical mask and spacer designed for cats. A model incorporating three-dimensional cat airway geometry, a commercially available spherical mask, and a 10 cm spacer, was used for CFD analysis. Two peak inspiratory flows were tested: 30 mL/s and 126 mL/s. Simulations were performed with 30s breathing different inspiratory and expiratory times, respiratory frequencies and peaks. Droplet spray transport and deposition were simulated with different particle sizes typical of the drug delivery therapies (1, 5, 10, and 15 μm). The percentage of particle deposition into the device and upper airways decreased with increasing particle diameter during both flows imposed in this cat model. During increased mean ventilatory rate (MVR) conditions, most of the salbutamol was lost in the upper airways. And during decreased MVR conditions, most of the particles remained in suspension (still in hold-up) between the mask and the carina, indicating the need for more than 30 s to be transported. In both flows the percentage of particles traveling to the lung was low at 1.5%-2.3%. In conclusion, in contrast to what has been described in the human literature, the results from this feline model suggest that the percentage of particles deposited on the upper airway decreases with increasing particle diameter.
沙丁胺醇是一种支气管扩张剂,常用于治疗猫的炎性下呼吸道疾病,包括哮喘或急性支气管痉挛。与人类一样,压力定量吸入器(pMDI)与储雾罐和球形面罩配合使用,以方便沙丁胺醇给药。然而,吸入疗法的疗效受到不同因素的影响,包括猫不配合的特性。在本研究中,目标是使用计算流体动力学(CFD),通过专为猫设计的特定球形面罩和储雾罐,分析呼吸模式和沙丁胺醇颗粒大小对整体药物传输和沉积的影响。一个包含三维猫气道几何结构、市售球形面罩和10厘米储雾罐的模型用于CFD分析。测试了两个吸气峰值流速:30毫升/秒和126毫升/秒。模拟了30秒不同吸气和呼气时间、呼吸频率和峰值的呼吸情况。用药物递送疗法中典型的不同颗粒大小(1、5、10和15微米)模拟液滴喷雾传输和沉积。在该猫模型施加的两种流速下,进入装置和上呼吸道的颗粒沉积百分比均随颗粒直径增加而降低。在平均通气率(MVR)增加的情况下,大多数沙丁胺醇在上呼吸道中损失。而在MVR降低的情况下,大多数颗粒仍悬浮在面罩和隆突之间(仍处于滞留状态),这表明需要超过30秒才能传输。在两种流速下,到达肺部的颗粒百分比都很低,为1.5%-2.3%。总之,与人类文献中所描述的情况相反,该猫模型的结果表明,沉积在上呼吸道的颗粒百分比随颗粒直径增加而降低。